Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! But meanwhile -- Videos from...
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time! But meanwhile -- Videos from...
For this series of case based panel discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie Brahmer to discuss treatment for...
Dr. Alice Shaw joined GRACE to discuss the changing landscape of first-line treatment of ALK-positive advanced non-small cell lung cancer.
Dr. Alice Shaw joined GRACE to discuss patterns of resistance in ALK positive non small cell lung cancer.
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Probably the most immediate potentially practice-changing presentation from ASCO was the Japanese J-ALEX study in the subset of about 4-5% of patients...
But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available!
But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available!
This past event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is now going to be held live online this Saturday, September 12, 2020.
MARCH 28, PUT IN ON YOUR CALENDARS.
I always learn so much at the live patient forums even attending them virtually.
Our faculty is outstanding in their field not only because of their work in groundbreaking research and exceptional patient care they are also leaders in the field of Shared Decision Making or SDM. We're lucky to have this opportunity to learn from and ask questions of these oncologists and patient advocates.
I hope to see you in Boston, well for me to share this experience virtually,
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.